| REcovery of Left Ventricular Dysfunction in CAncer Patients (RECAP Trial) (NCT02543294) | M.D. Anderson Cancer Center | 2012-09-10 |
| Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies (NCT03458676) | M.D. Anderson Cancer Center | 2012-09-06 |
| Exemestane-RAD001-Metformin (NCT01627067) | M.D. Anderson Cancer Center | 2012-09-01 |
| The Effect of Dexmedetomidine of the Immune System (NCT01692210) | M.D. Anderson Cancer Center | 2012-09-01 |
| Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC) (NCT01333423) | M.D. Anderson Cancer Center | 2012-09-01 |
| An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor (NCT01619774) | M.D. Anderson Cancer Center | 2012-09-01 |
| Neurofeedback in Decreasing Acute Radiotherapy-Induced Pain in Patients With Head and Neck Cancer (NCT02543320) | M.D. Anderson Cancer Center | 2012-08-29 |
| Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML) (NCT01460498) | M.D. Anderson Cancer Center | 2012-08-08 |
| R-21 Colorectal Cancer Screening (CRCS) Pilot Trial (NCT01492049) | M.D. Anderson Cancer Center | 2012-08-07 |
| A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy (NCT01624220) | M.D. Anderson Cancer Center | 2012-08-03 |
| Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 (NCT01593020) | M.D. Anderson Cancer Center | 2012-08-03 |
| Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Treating Patients With Newly Diagnosed Non-melanoma Brain Metastases (NCT01592968) | M.D. Anderson Cancer Center | 2012-08-02 |
| Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases (NCT01644591) | M.D. Anderson Cancer Center | 2012-08-02 |
| Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT) (NCT01511081) | M.D. Anderson Cancer Center | 2012-08-01 |
| A Study of the HSP90 Inhibitor AUY922 (NCT01485536) | M.D. Anderson Cancer Center | 2012-08-01 |
| Lacosamide in Preventing Seizures in Participants With Malignant Glioma (NCT01432171) | M.D. Anderson Cancer Center | 2012-07-25 |
| Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot Project (NCT02459002) | M.D. Anderson Cancer Center | 2012-07-18 |
| Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies (NCT01471067) | M.D. Anderson Cancer Center | 2012-07-13 |
| Genomic Profiling Assay in Phase I (NCT02437617) | M.D. Anderson Cancer Center | 2012-07-13 |
| Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer (NCT01505868) | M.D. Anderson Cancer Center | 2012-07-11 |
| Study of Vemurafenib, Carboplatin, and Paclitaxel (NCT01636622) | M.D. Anderson Cancer Center | 2012-07-09 |
| Social Determinants and Smoking Cessation (NCT01310842) | M.D. Anderson Cancer Center | 2012-07-01 |
| Imaging Study Compare 4DCT Image (NCT01626001) | M.D. Anderson Cancer Center | 2012-07-01 |
| A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women (NCT01605656) | M.D. Anderson Cancer Center | 2012-07-01 |
| Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma (NCT01582152) | M.D. Anderson Cancer Center | 2012-07-01 |
| Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy (NCT01636934) | M.D. Anderson Cancer Center | 2012-07-01 |
| Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias (NCT01396499) | M.D. Anderson Cancer Center | 2012-07-01 |
| Aerosolized Aldesleukin in Treating Patients With Lung Metastases (NCT01590069) | M.D. Anderson Cancer Center | 2012-06-28 |
| Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome (NCT01624805) | M.D. Anderson Cancer Center | 2012-06-25 |
| Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers (NCT01624766) | M.D. Anderson Cancer Center | 2012-06-19 |
| Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas (NCT01560949) | M.D. Anderson Cancer Center | 2012-06-14 |
| An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357) (NCT01498445) | M.D. Anderson Cancer Center | 2012-06-12 |
| Young-Onset Colorectal Cancer (NCT02863107) | M.D. Anderson Cancer Center | 2012-06-07 |
| Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation Therapy (NCT01808677) | M.D. Anderson Cancer Center | 2012-06-01 |
| Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the Cervix (NCT01606293) | M.D. Anderson Cancer Center | 2012-05-24 |
| A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity (NCT01262664) | M.D. Anderson Cancer Center | 2012-05-24 |
| Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes (NCT02863172) | M.D. Anderson Cancer Center | 2012-05-22 |
| Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer (NCT01582191) | M.D. Anderson Cancer Center | 2012-05-14 |
| Lenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM) (NCT01531998) | M.D. Anderson Cancer Center | 2012-05-01 |
| Lifestyle Intervention for High Risk Cancer Survivors (NCT01508273) | M.D. Anderson Cancer Center | 2012-05-01 |
| Fosaprepitant in Patients Receiving Ifosfamide-based Regimen (NCT01490060) | M.D. Anderson Cancer Center | 2012-05-01 |
| Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial (NCT01512589) | M.D. Anderson Cancer Center | 2012-04-30 |
| New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality (NCT03980535) | M.D. Anderson Cancer Center | 2012-04-16 |
| Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning (NCT01572662) | M.D. Anderson Cancer Center | 2012-04-11 |
| Breakthrough Dyspnea Fentanyl Study in Cancer Patients (NCT01515566) | M.D. Anderson Cancer Center | 2012-04-01 |
| Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP) (NCT01570868) | M.D. Anderson Cancer Center | 2012-04-01 |
| Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide (NCT01200004) | M.D. Anderson Cancer Center | 2012-04-01 |
| Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer (NCT01548144) | M.D. Anderson Cancer Center | 2012-04-01 |
| Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis (NCT01409200) | M.D. Anderson Cancer Center | 2012-03-26 |
| Temsirolimus in Combination With Metformin in Patients With Advanced Cancers (NCT01529593) | M.D. Anderson Cancer Center | 2012-03-26 |
| Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT01504126) | M.D. Anderson Cancer Center | 2012-03-09 |
| Selective Image Guided Resection of Axillary Lymph Nodes (NCT01880645) | M.D. Anderson Cancer Center | 2012-03-01 |
| Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation (NCT01536392) | M.D. Anderson Cancer Center | 2012-03-01 |
| Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy (NCT01938716) | M.D. Anderson Cancer Center | 2012-03-01 |
| Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS) (NCT01542684) | M.D. Anderson Cancer Center | 2012-03-01 |
| Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass (NCT01433302) | M.D. Anderson Cancer Center | 2012-03-01 |
| Erlotinib in Combination With Pralatrexate in Advanced Malignancies (NCT01532011) | M.D. Anderson Cancer Center | 2012-03-01 |
| Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program (NCT01772771) | M.D. Anderson Cancer Center | 2012-03-01 |
| Phase 2 Study of the Combination of Bruton's Tyrosine Kinase Inhibitor PCI-32765 and Rituximab in High-Risk Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients (NCT01520519) | M.D. Anderson Cancer Center | 2012-02-27 |
| Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia (NCT01372540) | M.D. Anderson Cancer Center | 2012-02-24 |
| Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy (NCT01410942) | M.D. Anderson Cancer Center | 2012-02-08 |
| Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) (NCT01515527) | M.D. Anderson Cancer Center | 2012-02-07 |
| Part II: Exercise in Hispanic Breast Cancer Survivors (NCT01504789) | M.D. Anderson Cancer Center | 2012-02-07 |
| Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations (NCT01531361) | M.D. Anderson Cancer Center | 2012-02-06 |
| Study of 18F-Fluoro-PEG6-IPQA (NCT01320059) | M.D. Anderson Cancer Center | 2012-02-01 |
| Rocking Motion: Physiologic Effect on the Surgical Stress Response (NCT01200316) | M.D. Anderson Cancer Center | 2012-02-01 |
| Natural History of Lung Nodules Seen on CT Scans From Participants at High-Risk of Developing Lung Cancer (NCT01540552) | M.D. Anderson Cancer Center | 2012-02-01 |
| Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT) (NCT01518153) | M.D. Anderson Cancer Center | 2012-02-01 |
| Comparison of a Novel 22-gauge Core Biopsy Needle (NCT01598194) | M.D. Anderson Cancer Center | 2012-01-30 |
| TKI258 for Metastatic Inflammatory Breast Cancer Patients (NCT01262027) | M.D. Anderson Cancer Center | 2012-01-27 |
| Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas (NCT01438476) | M.D. Anderson Cancer Center | 2012-01-26 |
| Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy (NCT01388777) | M.D. Anderson Cancer Center | 2012-01-24 |
| Pazopanib Hydrochloride in Treating Patients With Von Hippel-Lindau Syndrome (NCT01436227) | M.D. Anderson Cancer Center | 2012-01-17 |
| Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy (NCT01428635) | M.D. Anderson Cancer Center | 2012-01-13 |
| Medical Data Collection of Patients With Head and Neck Cancer Treated With Proton Therapy (NCT01627093) | M.D. Anderson Cancer Center | 2012-01-06 |
| Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG (NCT01390402) | M.D. Anderson Cancer Center | 2012-01-01 |
| Reducing Cancer Disparities Among Latinos in Texas (NCT01504919) | M.D. Anderson Cancer Center | 2012-01-01 |
| Determinants of Multiple Health Risk Behaviors Among Latinos (NCT01479257) | M.D. Anderson Cancer Center | 2012-01-01 |
| Respiratory Syncytial Virus - RSV Protocol (NCT01502072) | M.D. Anderson Cancer Center | 2011-12-28 |
| Ofatumumab as Front-Line Therapy in Treating Elderly Participants With Chronic Lymphocytic Leukemia (NCT01444716) | M.D. Anderson Cancer Center | 2011-12-15 |
| Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL) (NCT01446133) | M.D. Anderson Cancer Center | 2011-12-12 |
| Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia (NCT01266044) | M.D. Anderson Cancer Center | 2011-12-09 |
| Long-Term Follow-Up of Recipient of Gene Transfer Research (NCT01492036) | M.D. Anderson Cancer Center | 2011-12-09 |
| Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT) (NCT01469247) | M.D. Anderson Cancer Center | 2011-12-07 |
| SB1518 for Patients With Myelodysplastic Syndrome (MDS) (NCT01436084) | M.D. Anderson Cancer Center | 2011-12-01 |
| Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood (NCT01497184) | M.D. Anderson Cancer Center | 2011-12-01 |
| Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS) (NCT01444742) | M.D. Anderson Cancer Center | 2011-11-16 |
| Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) (NCT01471444) | M.D. Anderson Cancer Center | 2011-11-02 |
| In Vivo Dosimetry During Prostate Cancer Radiotherapy (NCT01307852) | M.D. Anderson Cancer Center | 2011-11-01 |
| Preoperative Treatment With Cetuximab and/or IMC-A12 (NCT00957853) | M.D. Anderson Cancer Center | 2011-10-17 |
| The Effects of Ginseng on Cancer-Related Fatigue (NCT01375114) | M.D. Anderson Cancer Center | 2011-10-14 |
| Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients (NCT01430572) | M.D. Anderson Cancer Center | 2011-10-07 |
| Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease (NCT03050762) | M.D. Anderson Cancer Center | 2011-10-05 |
| Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia (NCT01424982) | M.D. Anderson Cancer Center | 2011-10-05 |
| Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia (NCT01409161) | M.D. Anderson Cancer Center | 2011-10-05 |
| Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors (NCT01454804) | M.D. Anderson Cancer Center | 2011-10-01 |
| Pegasys in Patients With Chronic Myeloid Leukemia (CML) (NCT01392170) | M.D. Anderson Cancer Center | 2011-10-01 |
| IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma (NCT01409187) | M.D. Anderson Cancer Center | 2011-10-01 |
| Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L) (NCT01201694) | M.D. Anderson Cancer Center | 2011-10-01 |
| A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma (NCT01413178) | M.D. Anderson Cancer Center | 2011-09-30 |